| DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia RE Rau, BA Rodriguez, M Luo, M Jeong, A Rosen, JH Rogers, ... Blood, The Journal of the American Society of Hematology 128 (7), 971-981, 2016 | 130 | 2016 |
| MIR-23A microRNA cluster inhibits B-cell development KY Kong, KS Owens, JH Rogers, J Mullenix, CS Velu, HL Grimes, R Dahl Experimental hematology 38 (8), 629-640. e1, 2010 | 128 | 2010 |
| Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status GJ Roboz, F Ravandi, AH Wei, H Dombret, F Thol, MT Voso, AC Schuh, ... Blood, The Journal of the American Society of Hematology 139 (14), 2145-2155, 2022 | 50 | 2022 |
| AML and the art of remission maintenance M de Lima, GJ Roboz, U Platzbecker, C Craddock, G Ossenkoppele Blood Reviews 49, 100829, 2021 | 20 | 2021 |
| Differentiation syndrome with lower‐intensity treatments for acute myeloid leukemia AT Fathi, EM Stein, CD DiNardo, MJ Levis, P Montesinos, S de Botton American journal of hematology 96 (6), 735-746, 2021 | 20 | 2021 |
| Oral azacitidine (CC-486) for the treatment of myeloid malignancies G Garcia-Manero, H Döhner, AH Wei, I La Torre, B Skikne, CL Beach, ... Clinical Lymphoma Myeloma and Leukemia 22 (4), 236-250, 2022 | 17 | 2022 |
| E2A antagonizes PU. 1 activity through inhibition of DNA binding JH Rogers, KS Owens, J Kurkewich, N Klopfenstein, SR Iyer, MC Simon, ... BioMed Research International 2016 (1), 3983686, 2016 | 12 | 2016 |
| Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4 KY Kong, EA Williamson, JH Rogers, T Tran, R Hromas, R Dahl Blood, The Journal of the American Society of Hematology 114 (1), 60-63, 2009 | 12 | 2009 |
| Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities JH Rogers, R Gupta, JM Reyes, MC Gundry, G Medrano, A Guzman, ... Blood Advances 5 (19), 3876-3890, 2021 | 11 | 2021 |
| A comprehensive diagnostic offering workflow increases the rate of actionable results of the 23-and 35-gene expression profile tests for use as ancillary diagnostic tools for … M Goldberg, J Siegel, B Russell, J Rogers, K Covington, K Oelschlanger, ... SKIN The Journal of Cutaneous Medicine 5 (6), s79-s79, 2021 | 3 | 2021 |
| Oral mucosa harbors a high frequency of endothelial cells: a novel postnatal cell source for angiogenic regeneration J Zhou, JH Rogers, SH Lee, DM Sun, H Yao, JJ Mao, KY Kong Stem Cells and Development 26 (2), 91-101, 2017 | 3 | 2017 |
| A Physician’s Guide to the Use of Gene Expression Profile Ancillary Diagnostic Testing for Cutaneous Melanocytic Neoplasms E Marks, A Jarell, J Ludzik, AS Farberg, HS Rabinovitz, RG Phelps, ... The Journal of Clinical and Aesthetic Dermatology 16 (4), 12, 2023 | 2 | 2023 |
| Precise modeling of IKZF1 alterations in human B-cell acute lymphoblastic leukemia cell lines reveals distinct chemosensitivity, homing, and engraftment properties JH Rogers, R Gupta, JM Reyes, L Brunetti, MC Gundry, T Song, ... Blood 132, 549, 2018 | 2 | 2018 |
| The American Boeing and the European Airbus: Competition for aviation technology and markets. A comprehensive analysis J Rogers Rochester Institute of Technology, 2006 | 2 | 2006 |
| Uveal melanoma patient attitudes towards prognostic testing using gene expression profiling BK Williams Jr, JJ Siegel, KM Alsina, L Johnston, A Sisco, K LiPira, ... Melanoma Management 9 (3), MMT62, 2022 | 1 | 2022 |
| Targeting signaling pathways vulnerabilities for the treatment of IKZF1-deleted ph-negative B lymphoblastic leukemia. R Gupta, JH Rogers, X Long, R Aguilar, G Medrano, J Reyes, M Redell, ... Journal of Clinical Oncology 40 (16_suppl), 7033-7033, 2022 | 1 | 2022 |
| Targeting activated signaling pathways for the treatment of IKZF1-deleted B lymphoblastic leukemia R Gupta, JH Rogers, X Long, G Medrano, JM Reyes, M Redell, ZT Ball, ... Blood 134, 3789, 2019 | 1 | 2019 |
| REMARKS ON COTTAM'S SPRING-BED, AND ON THE PREVENTION OF BED-SORES. JH Rogers The Lancet 54 (1372), 633-634, 1849 | 1 | 1849 |
| Dose-dependent effects of Dnmt3a in an inducible murine model of KrasG12D-driven leukemia JH Rogers, A Rosen, JM Reyes, S Ketkar, SE Conneely, R Gupta, L Yang, ... Experimental Hematology, 104248, 2024 | | 2024 |
| The impact of surface orientation on surface roughness and fatigue life of laser-based powder bed fusion Ti-6Al-4V J Rogers, J Elambasseril, C Wallbrink, B Krieg, M Qian, M Brandt, M Leary Additive Manufacturing 85, 104149, 2024 | | 2024 |
Margaret GoodellBaylor College of MedicineVerified email at bcm.edu
